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Abstract
Background: Rising hospital care costs have created pressure to shorten hospital stays and empha-
size outpatient care. This study tests the hypothesis that shorter median length of stay (LOS) as a
dialysis facility practice is associated with higher rates of early readmission.
Methods: Readmission within 30 days of each hospitalization was evaluated for participants in
the Dialysis Outcomes and Practice Patterns Study, an observational study of randomly selected hemo-
dialysis patients in the United States (142 facilities, 5095 patients with hospitalizations), five European
countries (101 facilities, 2281 patients with hospitalizations), and Japan (58 facilities, 883 patients with
hospitalizations). Associations between median facility LOS (estimated from all hospitalizations at the
facility and interpreted as a dialysis facility practice pattern) and odds of readmission were assessed
using logistic regression, adjusted for patient characteristics and the LOS of each index hospitalization.
Results: Risk of readmission was directly and significantly associated with LOS of the index hospitaliza-
tion (adjusted odds ratio [AOR] 1.005 per day in median facility LOS, p¼0.007) and inversely associated
with median facility LOS (AOR¼0.974 per day, p¼0.016). This latter association was strongest for US
hemodialysis centers (AOR¼0.954 per day, p¼0.015).
Conclusions: Dialysis facilities with shorter median hospital LOS for their patients have higher odds of
readmission, particularly in the United States, where there is greater pressure to shorten LOS. The
determinants and consequences of practices related to hospital LOS for hemodialysis patients should be
further studied.
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INTRODUCTION
Hemodialysis patients face an increased risk of hos-
pitalization because of a high prevalence of comorbid
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conditions and treatment-related complications.1–5
National data for end-stage renal disease patients treated
in the United States show a decrease in the number of
days per admission from 1993 to 1997, after adjusting for
age, sex, race, and the diagnosis of diabetes mellitus.6 By
contrast, the average annual hospitalization cost per
patient has increased over time. The trend toward shorter
hospital length of stay (LOS) for dialysis patients is con-
sistent with incentives to reduce health care costs.6
The pressure to shorten hospitalization stays may lead
to premature discharge in some cases.7–9 A potential
consequence of premature discharge is an increase in
unplanned early readmissions, a proposed marker of the
quality of in-hospital and postdischarge care.10,11 The
consequences of premature discharge may be worse for
dialysis patients (compared to several other groups of
patients) because of their high prevalence of comorbid
conditions and increased risk of complications.12–18
Hemodialysis facilities provide a unique opportunity
for evaluating the effect of hospital LOS practice on
readmission risk because they function as logically uni-
fied practice units. Hospitalization practices for patients
receiving regular treatment in a dialysis facility typically
involve a small and cohesive group of providers, consult-
ants, and hospitals. Furthermore, the hospital LOS prac-
tice of a dialysis facility can be measured with reasonable
accuracy because dialysis patients as a group require
frequent hospitalization.4 The facility LOS practice pat-
tern is captured by the median LOS of all hospitalizations
of facility patients. Practitioners associated with dialysis
facilities with a high median LOS tend to keep their
patients in the hospital longer than do practitioners work-
ing in facilities with a shorter median LOS. The concept
of LOS as a practice pattern seems to be especially appro-
priate for hemodialysis patients because their care is
largely organized at the dialysis facility level and they
are hospitalized more frequently than many other patient
groups. Hospital LOS is more difficult to express as a
practice pattern for other patient groups because the
practice unit is typically a single physician, and hospital-
ization is relatively infrequent.
This study examines the relationship between readmis-
sion and LOS for hemodialysis patients, using nationally
representative samples of dialysis facilities and patients
from France, Germany, Italy, Japan, Spain, the United
Kingdom, and the United States. The LOS for each indi-
vidual hospitalization was interpreted as an indicator of
the severity of the condition for which each patient was
hospitalized. The median LOS for each dialysis facility
was interpreted as a marker of the local practice pattern.
The study hypothesized that the risk of readmission was
directly associated with individual hospital LOS (severity
of disease) and inversely associated with median facility
LOS (practice pattern).
MATERIALS AND METHODS
The data used for the present analysis were from the
Dialysis Outcomes and Practice Patterns Study (DOPPS I),
an international, prospective, observational study of
hemodialysis practice patterns and associated outcomes.
The study is ongoing in the United States (US-DOPPS),
five European countries (referred to collectively as Euro-
DOPPS: France, Germany, Italy, Spain, and the United
Kingdom), and Japan (Japan-DOPPS).19 Nationally repre-
sentative samples of dialysis facilities were recruited in
each country. The study was reviewed and approved by
the appropriate institutional review boards in each coun-
try and in selected facilities. The overall design of the
DOPPS has been described previously.19
The current study included data from 142 hemodialy-
sis facilities in the United States (5095 patients with at
least one hospitalization), 101 facilities in Europe (2281
patients with hospitalizations), and 58 facilities in Japan
(883 patients with hospitalizations). Data collection
began in 1997 in the United States, 1998 in Europe,
and 1999 in Japan. Patients were replaced on an ongoing
basis as they left participating facilities for reasons of
death, transplantation, change in treatment modality,
withdrawal from dialysis, recovery of renal function, or
transfer to another facility.
At the time of enrollment of each new patient, the
medical record was abstracted for extensive information
about demographic characteristics, comorbid conditions,
laboratory values, and renal diagnosis. Follow-up infor-
mation was obtained approximately every 4 months
including dates, diagnoses, and procedures associated
with each hospitalization.
For hospitalizations during the study period with at
least 30 days of postdischarge follow-up, a readmission
was defined as a hospital admission within 30 days of the
previous discharge. Readmission risk was modeled using
logistic regression. Potential associations among the prob-
abilities of readmission for multiple hospitalizations of
the same patient were modeled using a compound
symmetry (i.e., exchangeable) correlation structure. SAS
software, version 8 (SAS Institute; Cary, NC), was used
for all analyses.
The facility practice pattern for hospital LOS was esti-
mated as the median LOS of all hospitalizations of
patients at that facility, excluding hospitalizations asso-
ciated with death. The logistic models of readmission risk
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simultaneously included both the LOS associated with
each hospitalization (hospital LOS) and the dialysis facil-
ity median LOS (as a facility practice pattern). Models
were adjusted for 27 covariates, including demographic
characteristics, socioeconomic factors, reason for hospital-
ization, comorbid conditions, dialysis dose (estimated as
the equilibrated Kt/Vurea [eKt/Vurea])
20 hematocrit, phos-
phorus, years on dialysis, and the country where the
patient was treated. Hospital and facility median LOS
were modeled as both categorical and continuous vari-
ables to fully explore the functional relationships of inter-
est. The primary reason for each hospital admission was
grouped (on the data collection code sheet) into the
following 15 categories: infectious disease, vascular
access, coronary heart disease, other cardiac disease
(i.e., congestive heart failure, arrhythmias, and valvular
and pericardial disease), peripheral vascular disease,
cerebrovascular or neurologic disease, musculoskeletal
disease, pulmonary disease, gastrointestinal or hepatic
disease, endocrine or metabolic disease, cancer, visual
disease, trauma or injury-related condition, psychiatric
disease, and health maintenance or routine care.
RESULTS
Table 1 shows the baseline patient characteristics that
were used for model-adjustment purposes. In general,
the patient sample was enriched with elderly patients
with multiple comorbid conditions, representative of
the chronic hemodialysis population. The mean patient
age was 61.5 14.8 (SD) years. The sample compos-
ition was 21.5% black and 56.0% male. More than
50% of the patients were on dialysis for less than 1 year.
Almost one-fourth of patients were living alone or in a
setting indicative of diminished independence or
social support. The prevalence of comorbid conditions
was high, particularly for hypertension, coronary artery
disease, diabetes, and congestive heart failure. As
expected, large variation was seen in patient measure-
ments, such as body mass index, dialysis dose, serum
phosphorus and albumin concentration, and the blood
hematocrit. These variables were included in the read-
mission models because they are known predictors of
patient morbidity.
The overall hospital readmission rate was 26.2% (Table
2). Of these readmissions, 44.3% were grouped in the
same diagnostic category as the initial hospitalization.
The percentage of patients who were readmitted varied
by diagnostic category of the initial hospitalization,
ranging from 12.2% for vision-related hospitalizations to
33.1% for hospitalizations related to cancer. Readmis-
sions within 30 days were frequently categorized in the
same diagnostic group as the initial hospitalization, par-
ticularly for hospitalizations related to cancer (66.4%),
vascular access (56.7%), and peripheral vascular disease
(50.4%). Because reasons for hospitalization were not
independent, reasons for initial hospital admission or
readmission that were considered likely to be related
were combined. Data (not presented in Table 2) showed
that 63.4% of patients with an initial admission caused by
coronary heart disease or other cardiac diseases were
readmitted within 30 days for one of these same initial
reasons. These two cardiac causes were also combined
with peripheral vascular disease and cerebrovascular/
neurologic disease; 72.4% of patients with one of these
reasons for the index hospitalization had a readmission
within 30 days attributable to one of these problems.
Information about the reason for the initial admission
was missing for 10% of hospitalizations.
The percentages of hospitalizations with LOS less
than 3, 3 to 4, 5 to 9, and more than 9 days were 29%,
20%, 25%, and 26%, respectively. Hospital LOS also was
characterized as a facility practice pattern, expressed as
the median LOS for hospitalizations of facility patients
that did not result in death. The median facility LOS
estimated the overall hospitalization duration practice
for a facility. Table 3 shows that the median facility LOS
was shortest for US-DOPPS centers (median 4 days) and
longest for Japan-DOPPS (median 12.5 days). Median
LOS equal to or shorter than 5 days was seen in 85% of
facilities in US-DOPPS, 48% in Euro-DOPPS, and 5% in
Japan-DOPPS.
Figure 1 displays the association between readmission
risk and LOS, adjusted for patient characteristics (shown
in Table 1), reason for hospitalization (Table 2), and
country. The risk of readmission (expressed as the
adjusted odds ratio [AOR]) was directly associated with
the length of the initial (index) hospitalization (Fig. 1A).
The readmission risk increased with index hospitalization
LOS in a dose-dependent fashion for LOS greater than
4 days; admissions longer than 9 days had significantly
greater risk of readmission than did admissions shorter
than 3 days (AOR 1.18; p¼ 0.001). In contrast, Fig. 1B
shows that, when the data of the whole group of patients
in the facility were used to determine the median LOS,
facilities with longer LOS had lower odds of readmission.
The odds of readmission were significantly lower (12%)
for dialysis facilities with a median LOS longer than
5 days compared with median LOS less than 4 days
(AOR 0.88, p¼ 0.05). In other words, readmission was
less likely in facilities with a practice of longer hospital-
izations, adjusted for multiple patient characteristics,
Hospitalization length/readmission risk
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reason for hospitalization, index hospitalization LOS,
and country.
For each country, the average median facility LOS and
the average of the percentage of readmission in each
facility were determined. Figure 2 shows an inverse
correlation between the country average median facility
LOS and the average percentage of readmission (Pearson
correlation, r¼0.87).
Table 4 shows the association between readmission
and LOS, expressed as a continuous variable, for all-
DOPPS, US-DOPPS, Euro-DOPPS, and Japan-DOPPS.
The AOR estimates the relative odds of readmission
Table 1 Baseline patient characteristics for the Dialysis Outcomes and Practice Patterns Study (DOPPS) participants with at
least one hospitalization (n¼ 8259)
% or mean SD*
Demographic characteristics
Age (years) 61.5 14.8
Black 21.5
Male 56.0









Cancer (other than skin) 10.7
Cerebrovascular disease 18.6
Congestive heart failure 40.5








Other cardiovascular disease 35.4
Peripheral vascular disease 26.9
Psychiatric disorder 25.0
Recurring cellulitis, gangrene 9.5
Patient measurements
Body mass index (kg/m2) 24.3 5.4
eKt/Vurea (adjusted for time of blood draw) 1.2 0.3
Phosphorus at enrollment 5.7 1.9
Albumin at enrollment 3.6 0.6
Hematocrit at enrollment 31.0 5.3





*Unless specified to be median (years on dialysis); SD¼ standard deviation.
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associated with one additional index hospital day and
a 1-day increase in the median facility LOS. As in Fig. 1,
each model was simultaneously adjusted for both hospital
and median facility LOS. For all-DOPPS, the risk of
readmission was approximately 0.5% higher for each
additional index hospital day and approximately 2% to
3% lower for each additional median facility LOS. The
associations were similar with and without adjustment for
patient characteristics. The observed associations were
stronger in the US compared with both Europe and
Japan. In Europe and Japan, the associations were con-
sistent but not statistically significant.
DISCUSSION
This study examined the association between hospital
readmission and LOS. Early hospital readmission is
usually an undesirable event and represents an important,
if imperfect, quality indicator. The LOS of individual
hospitalizations was considered an indicator of severity
of illness and underlying patient status. In contrast, med-
ian dialysis facility LOS was used as an indicator of the
facility practice pattern for LOS. Although median facility
LOS was determined from individual hospital lengths of
stay for the facility’s patients, the two measures are statis-
tically and conceptually distinct. In fact, readmissions
were associated with these two LOS measures in very
different ways.
For individual hospitalizations, the risk of readmission
within 30 days of discharge was associated with longer
individual hospital stays (Fig. 1A, Table 4). This finding
was expected because longer hospital stays are generally
associated with more serious illness, which, in turn,
would increase the risk of subsequent hospitalization.
Table 2 Distribution of initial hospital admissions by diagnostic categories and percentage of readmissions within 30 days




% of All readmissions
due to the same reason
Overall 100 26.2 44.3
Coronary heart disease 8.4 27.2 40.2
Other cardiac diseases 9.3 27.7 38.4
Vascular access 22.6 26.8 56.7
Infectious disease 11.9 25.7 35.2
Peripheral vascular disease 6.3 30.8 50.4
Gastrointestinal or hepatic disease 9.2 24.7 40.9
Pulmonary disease 4.5 26.7 33.2
Cerebrovascular or neurologic disease 4.4 25.1 34.5
Endocrine or metabolic disease 3.6 26.2 36.9
Musculoskeletal disease 3.0 19.3 27.8
Cancer 1.8 33.1 66.4
Psychiatric or mental illness 1.2 32.0 18.8
Health maintenance or routine care 1.7 21.4 17.7
Trauma or injury-related condition 1.2 15.0 17.5
Vision related 0.7 12.2 27.8
Missing reason 10.0 25.6 54.5
Table 3 Distribution of median facility hospital length of stay (LOS), overall, and by Dialysis Outcomes and Practice Patterns
Study (DOPPS) location
All DOPPS US-DOPPS Euro-DOPPS Japan-DOPPS
Median of median facility LOS (days) 5.0 4.0 5.0 12.5
Average of median facility LOS (days) 6.9 4.3 6.6 13.6
Median facility LOS (% of facilities)
<4 days 19.0 23.0 22.0 3.0
4–5 days 38.0 62.0 26.0 2.0
>5 days 43.0 15.0 52.0 95.0
Hospitalization length/readmission risk
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By contrast, after adjustment for multiple patient charac-
teristics and the index hospitalization LOS, readmission
risk was inversely associated with the median facility LOS
(Fig. 1B, Table 4). As noted, median facility LOS is an
integrated measure of local hospitalization practice, as
determined by the practitioners, hospitals, and treatment
customs associated with each dialysis facility. These
results are consistent with the hypothesis that the risk of
hospital readmission is higher for patients who receive
dialysis treatment in facilities where a shorter hospital
LOS is the generally adopted practice. If variations in
facility median LOS were primarily the result of facility
differences in patient characteristics rather than in prac-
tice, then one might expect no facility LOS effect in
models that were adjusted for multiple patient character-
istics.
Early readmission has been interpreted as an indicator
of the quality of hospital and posthospital care.11 It is
recognized that some early readmissions are expected for
such situations as staged surgical interventions, cancer
therapy, and procedures that were appropriately sched-
uled during a prior hospitalization.21 In contrast,
unplanned early readmission suggests the possibility of
premature discharge or suboptimal care during the hos-
pitalization or following discharge.10,11,22–24 Potential
factors that may increase the risk of early readmission
include lack of diagnostic resources, incorrect treatment
selection, inadequate nursing care, nosocomial infections,
and a focus on a single problem in patients with multiple
comorbid conditions. Readmission risk is also related to
patient characteristics and the primary disease process.
In this analysis it was not possible to differentiate
planned from unplanned admissions.25 We observed,
however, a higher risk of readmission for hospitalizations
associated with certain disease categories such as cancer,
peripheral vascular diseases, and cardiac diseases (Table
2). A fraction of early readmissions among these patients
likely were planned. A more in-depth analysis of these
hospitalizations is necessary to identify the factors that































Individual hospitalization LOS (days) Median facility LOS (days)
A B
AOR AOR
Figure 1 The odds of hospital readmission (expressed as the adjusted odds ratio, AOR) was directly associated with hospital
length of stay (LOS, A) and inversely associated with median facility LOS (B).
Country average of facility median LOS





Country average of facility
% readmissions
Figure 2 Association between average dialysis facility read-
mission rate and average median length of stay (LOS) for each
country in the DOPPS (Pearson correlation, r¼0.87).
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contribute to unplanned readmissions. This analysis,
controlled for multiple factors that could plausibly
influence the risk of readmission, suggests that the
inverse association between shorter median facility LOS
and higher readmission risk stems partly from a systematic
tendency toward premature discharge of patients treated at
some dialysis facilities, particularly in the United States.
The association between shorter median facility LOS
and higher odds of readmission was strongest in the
US-DOPPS (Table 4). This finding may be related to
greater pressure to shorten LOS for dialysis patients in
the United States compared with Europe and, particu-
larly, Japan (Table 3, Fig. 2).4,26 The associations were
weaker and nonsignificant in Euro-DOPPS and Japan-
DOPPS, likely in part because of longer facility LOS
(Fig. 2) and/or smaller sample size. It is possible that
the trend toward shorter LOS for dialysis patients in the
United States is driven by the Medicare prospective pay-
ment system, which provides a financial incentive for
shorter hospital stays.27 The incentive to shorten LOS is
apparently weaker in other countries, particularly in
Japan.26,28 In fact, the longer hospital LOS in Japan
seems to be a general phenomenon rather than a finding
specific for hemodialysis patients. It is possible that the
hospital LOS practices in Europe and Japan exceed the
threshold at which a measurable impact on readmission
risk can be detected.
These data do not permit an assessment of the cost
tradeoff between shorter LOS and higher readmission
risk. Others have shown a diminishing impact of incre-
mental hospital days on total hospitalization costs.29
Nevertheless, hospitalization costs per dialysis patient
have increased over time even as LOS has declined in
the United States.4 The increased risk of early readmis-
sion in dialysis facilities with lower median LOS raises
important questions about the quality of in-hospital care
and discharge planning for dialysis patients.
In conclusion, our findings indicate that patients
treated in dialysis facilities with lower median LOS pres-
ent higher odds of readmission when taking into account
disease severity and reason for admission. The association
was stronger in the United States, where there is a great
emphasis to reduce LOS. The increase in the odds of
readmission in facilities with shorter median LOS sug-
gests incomplete resolution of the problems of hospital-
ized hemodialysis patients, particularly in the United
States. Hospitalization practice may be better tailored to
patient needs in Euro-DOPPS and Japan-DOPPS than in
US-DOPPS. These findings, based on observational data
from a sample of dialysis patients and facilities, should be
confirmed using other sources of hospital data. Addi-
tional research is needed to understand the quality and
cost implications of hospital LOS practices.
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Table 4 Associations between readmission and hospital length of stay (LOS), based on individual hospitalization LOS and
facility LOS
Odds ratio (95% confidence interval)
per 1-day increase in individual
hospitalization LOS
Odds ratio (95% confidence interval)
per 1-day increase in median
facility LOS
Unadjusted Adjusted* Unadjusted Adjusted*
All-DOPPS 1.006 (1.002–1.009) 1.005 (1.001–1.008) 0.979 (0.959–1.000) 0.974 (0.954–0.995)
p < 0.001 p¼ 0.007 p¼ 0.050 p¼ 0.016
US-DOPPS 1.008 (1.004–1.012) 1.007 (1.003–1.012) 0.959 (0.924–0.996) 0.954 (0.919–0.991)
p < 0.001 p¼ 0.001 p¼ 0.028 p¼ 0.015
Euro-DOPPS 1.004 (0.999–1.010) 1.003 (0.998–1.009) 1.010 (0.972–1.049) 0.996 (0.958–1.036)
p¼ 0.097 p¼ 0.276 p¼ 0.606 p¼ 0.852
Japan-DOPPS 1.005 (0.989–1.021) 0.999 (0.989–1.009) 0.980 (0.945–1.016) 0.994 (0.962–1.026)
p¼ 0.571 p¼ 0.885 p¼ 0.270 p¼ 0.693
*Adjusted for all variables listed in Table 1 and for country. All models include both patient LOS and facility median LOS.
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